CT-02(Captor Therapeutics)

N/A

Report date: 2025/08/08 14:36:38
NME

Base Information

Drug NameCT-02(Captor Therapeutics)
Drug Alias NameCT-02(Captor Therapeutics)
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionSerine/threonine-protein kinase Nek7 degraders
TargetsSerine/threonine-protein kinase Nek7
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaptor Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesCaptor Therapeutics SA
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A